CD44 levels were correlated with tumor aggressiveness in muscle-invasive BC patients [54], and it was observed that the tumorigenic potential of CD44+ tumor cells in immunocompromised mice was at least 10 to 200 times greater compared to that of CD44 cells [55]. The gene discussed is CD44; the disease is breast cancer.